Ablynx rejects Novo’s €2.3bn bidNanobody developer Ablynx NV has stated that the take-over cash price of €28 per share + optional €2.50 per share as Contingent Value Right (CVR) offered by Novo Nordisk A/S at the end of December … more ➔
Roche further expands in digital medicineGlobal theranostics major Roche expands its digitalised medicine portfolio. The next agreed project is a digital diagnostics platform to improve oncology and critical care treatment. more ➔
New method identifies harmful medicines metabolitesA new method to test the likelihood of a drug turning into a potentially harmful version of itself when it enters the body has been developed by researchers at Cardiff University. more ➔
Takeda bids €520m for TiGenixJapanese Pharma major Takeda had announced its intention to take over Belgian adipose stem cell therapy specialist Tigenix, which has already exclusively licenced its lead product darvadstrocel (Cx601) … more ➔
Boehringer Ingelheim expands Venture Funds to €250m German human and veterinay medicines major Boehringer Ingelheim has more than doubled the amount in funding of its Venture Fund (BIVF) to €250m. Additionally, the investment focus has been extended … more ➔
Addex inks US$339m deal with IndiviorSwiss allosteric modulation specialist Addex Therapeutics has licenced its GABA modulator ADX71441 to US addiction therapeutics expert Indivior plc. more ➔
Diabetes drug halts Alzheimer’s A triple receptor agonist developed for diabetes could be used to treat Alzheimer’s after scientists found it "significantly reversed memory loss" in mice through a triple mode of action. more ➔
What’s up in 2018?There is a lot of reports on technologies that have already entered the mainstream and will continue to grow in 2018 such as T-cell receptor targeted cancer, autoimmune and gene therapies. European Biotechnology … more ➔
Cancer senescence: licence to killTherapy-induced senescence (TIS), a lasting chemotherapy-evoked proliferative arrest of tumor cells, has been thought to be irreversible. As it turns out now, it makes tumour cells, which survive, more … more ➔
Sheets of eye cells improve retina repairScientists have generated sheets of human eye cells arranged on a biological scaffold, which they used to successfully treat vision disorders in rats. more ➔
